SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,477,988 | +12.1% | 180,306 | 0.0% | 2.32% | +2.2% |
| Q1 2023 | $7,565,640 | +10.0% | 180,306 | 0.0% | 2.27% | +17.1% |
| Q4 2022 | $6,876,871 | -2.6% | 180,306 | 0.0% | 1.94% | +2.0% |
| Q3 2022 | $7,061,000 | +21.2% | 180,306 | 0.0% | 1.90% | +19.7% |
| Q2 2022 | $5,824,000 | -2.4% | 180,306 | 0.0% | 1.59% | +2.1% |
| Q1 2022 | $5,968,000 | -22.2% | 180,306 | 0.0% | 1.56% | -19.4% |
| Q4 2021 | $7,670,000 | -4.0% | 180,306 | 0.0% | 1.93% | -9.0% |
| Q3 2021 | $7,989,000 | -17.4% | 180,306 | +5.9% | 2.12% | +4.8% |
| Q2 2021 | $9,675,000 | -28.7% | 170,306 | -6.1% | 2.02% | -37.2% |
| Q1 2021 | $13,571,000 | -13.5% | 181,306 | 0.0% | 3.22% | -31.0% |
| Q4 2020 | $15,685,000 | +62.1% | 181,306 | +14.5% | 4.67% | +48.4% |
| Q3 2020 | $9,676,000 | +40.8% | 158,306 | -4.2% | 3.14% | +58.6% |
| Q2 2020 | $6,873,000 | +44.8% | 165,306 | 0.0% | 1.98% | +0.1% |
| Q1 2020 | $4,748,000 | -47.3% | 165,306 | +32.5% | 1.98% | -36.0% |
| Q4 2019 | $9,010,000 | -48.5% | 124,806 | 0.0% | 3.09% | -53.0% |
| Q3 2019 | $17,509,000 | -22.8% | 124,806 | +0.8% | 6.58% | -22.7% |
| Q2 2019 | $22,668,000 | +15.1% | 123,806 | 0.0% | 8.52% | +0.3% |
| Q1 2019 | $19,691,000 | +97.1% | 123,806 | +18.7% | 8.50% | +71.0% |
| Q4 2018 | $9,991,000 | -28.8% | 104,306 | +5.0% | 4.97% | -13.8% |
| Q3 2018 | $14,027,000 | -6.7% | 99,306 | +3.4% | 5.76% | -18.1% |
| Q2 2018 | $15,027,000 | -0.8% | 96,000 | +2.1% | 7.04% | -4.5% |
| Q1 2018 | $15,141,000 | +219.2% | 94,000 | +226.4% | 7.37% | +188.3% |
| Q4 2017 | $4,744,000 | – | 28,800 | – | 2.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |